CUMBERLAND, RI – January 20, 2020 – TEDOR Pharma, a Contract Development and Manufacturing Organization with a 19-year operating history, is pleased to announce Frank Sorce is joining TEDOR as the new Regional Business Development Director. Sorce will be reporting to Chief Operating Officer, Terry Novak.
Frank Sorce brings with him 30 years of experience in pharmaceutical sales, marketing and business development. Mr. Sorce has held senior sales leadership positions including Regional Business Director with Reliant Pharmaceuticals, National Sales Director with Syneos Health, and Vice President of Business Development with UPM Pharmaceuticals.
Sorce began his career with Merck Sharpe & Dohme as a professional representative in Brooklyn, NY, and was an initial member of the Astra Merck Group. Mr. Sorce holds a BS degree in Management Science from Kean University, and an MBA in Marketing from Seton Hall University.
“Frank has a proven track record and we are excited to welcome him to the TEDOR team as we continue to build on our 2019 successes.,” said Doug Drysdale, President and Chief Executive Officer of TEDOR.”
About Tedor Pharma, Inc.
Founded in 2001, TEDOR Pharma is a specialized Contract Development and Manufacturing Organization with a strong track record of success in providing development and manufacturing services for oral solid dose products, including DEA-scheduled products, for life science customers. Over nearly two decades, TEDOR has helped customers meet their project timelines, achieve regulatory approvals, and solve formulation challenges. TEDOR offers services ranging from formulation development, clinical trial manufacturing, scale-up and full-scale commercial manufacturing, tech transfer, stability studies, and product life cycle management with patented FLEXITAB™ technology.